{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 73, "title": "Founder, CEO, President, Interim Principal Financial Officer & Executive Director", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 681200, "exercisedValue": 0, "unexercisedValue": 5637696}, {"maxAge": 1, "name": "Mr. Mark K. White", "age": 67, "title": "Chief Business Officer & Director", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen", "title": "Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.5, "open": 1.5, "dayLow": 1.45, "dayHigh": 1.66, "regularMarketPreviousClose": 1.5, "regularMarketOpen": 1.5, "regularMarketDayLow": 1.45, "regularMarketDayHigh": 1.66, "payoutRatio": 0.0, "beta": 1.65, "forwardPE": -0.82320446, "volume": 215337, "regularMarketVolume": 215337, "averageVolume": 509900, "averageVolume10days": 276280, "averageDailyVolume10Day": 276280, "bid": 1.43, "ask": 1.83, "bidSize": 11, "askSize": 31, "marketCap": 29034438, "fiftyTwoWeekLow": 1.43, "fiftyTwoWeekHigh": 20.0, "fiftyDayAverage": 2.5972, "twoHundredDayAverage": 6.55875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18482568, "profitMargins": 0.0, "floatShares": 15671217, "sharesOutstanding": 19486200, "sharesShort": 1879232, "sharesShortPriorMonth": 1443813, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0964, "heldPercentInsiders": 0.14446001, "heldPercentInstitutions": 0.13247, "shortRatio": 4.34, "shortPercentOfFloat": 0.11270001, "impliedSharesOutstanding": 19486200, "bookValue": 0.658, "priceToBook": 2.2644377, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -24590376, "trailingEps": -2.31, "forwardEps": -1.81, "52WeekChange": -0.8680248, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.49, "targetHighPrice": 72.0, "targetLowPrice": 8.0, "targetMeanPrice": 31.2, "targetMedianPrice": 26.0, "recommendationMean": 1.85714, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 10551916, "totalCashPerShare": 0.542, "totalDebt": 0, "quickRatio": 2.719, "currentRatio": 3.588, "returnOnAssets": -1.38265, "returnOnEquity": -31.59092, "freeCashflow": -12165856, "operatingCashflow": -21894604, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Annovis Bio, Inc.", "regularMarketChange": -0.00999999, "regularMarketDayRange": "1.45 - 1.66", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 509900, "fiftyTwoWeekLowChange": 0.060000062, "fiftyTwoWeekLowChangePercent": 0.041958086, "fiftyTwoWeekRange": "1.43 - 20.0", "fiftyTwoWeekHighChange": -18.51, "fiftyTwoWeekHighChangePercent": -0.92550004, "fiftyTwoWeekChangePercent": -86.80248, "earningsTimestamp": 1742591130, "earningsTimestampStart": 1746734400, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.31, "epsForward": -1.81, "epsCurrentYear": -0.78, "priceEpsCurrentYear": -1.9102565, "fiftyDayAverageChange": -1.1071999, "fiftyDayAverageChangePercent": -0.42630523, "twoHundredDayAverageChange": -5.0687504, "twoHundredDayAverageChangePercent": -0.7728226, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580308200000, "preMarketChange": 0.059999943, "preMarketChangePercent": 4.0268416, "preMarketPrice": 1.55, "longName": "Annovis Bio, Inc.", "corporateActions": [], "preMarketTime": 1743597999, "regularMarketTime": 1743537602, "exchange": "NYQ", "messageBoardId": "finmb_622711087", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "regularMarketChangePercent": -0.666666, "regularMarketPrice": 1.49, "marketState": "PRE", "displayName": "Annovis Bio", "trailingPegRatio": null}